GlassScriptPhysician profile
John David Ray
NPI 1346228889
$6,346.78
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $576 · 2021: $408 · 2022: $1,909 · 2023: $417 · 2024: $2,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Travel and Lodging: $976 · Royalty Or License: $623 · Entertainment: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.10 |
| Travel and Lodging | $976.04 |
| Royalty Or License | $623.00 |
| Entertainment | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,214.06 | 2019-2024 | Caliber, Caliber L, Allocate |
| Altus Partners. LLC | $1,931.28 | 2024 | |
| Alphatec Spine, INC | $1,603.90 | 2022 | |
| Boston Scientific Corporation | $160.15 | 2021 | |
| Stryker Corporation | $130.77 | 2022 | |
| Precision Spine, INC. | $118.94 | 2019 | |
| Depuy Synthes Sales INC. | $63.78 | 2020-2022 | |
| Spine Wave, INC. | $29.40 | 2024 | |
| Si-Bone, INC. | $28.10 | 2019-2020 | |
| Medtronic, INC. | $18.60 | 2022 | |
| Medtronic USA, INC. | $16.57 | 2019 | |
| Novo Nordisk INC | $15.91 | 2019 | |
| Misonix INC | $15.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.